🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Yunn‐Yi Chen

University of California, San Francisco

ORCID: 0000-0002-3346-8086
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity”.

Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity

Modern Pathology(2020)10.1038/s41379-019-0442-2
N/A
0DataRank · unranked
60 citations

Edaise M. da Silva, Denise Frosina, Felipe C. Geyer, John R. Lozada, Thais Basili +21 more

The molecular basis of breast cancer pathological phenotypes

UNC Libraries(2020)10.17615/p1q8-ts12
N/A
0DataRank · unranked
0 citations

Kristin C. Jensen, Yunn‐Yi Chen, Gregor Krings, Frederic M. Waldman, Yujing J. Heng +24 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256
N/A
0DataRank · unranked
20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Data from Protein Acetylation and Histone Deacetylase Expression Associated with Malignant Breast Cancer Progression

(2023)10.1158/1078-0432.c.6517428.v1
N/A
0DataRank · unranked
0 citations

Yunn‐Yi Chen, Gary K. Scott, Sandy DeVries, Koei Chin, Christopher C. Benz +3 more